What is the predictive value of established risk factors for total and cardiovascular disease mortality when measured before middle age? Pooled analyses of two prospective cohort studies from Scotland
Restricted accessResearch articleFirst published online February, 2010
What is the predictive value of established risk factors for total and cardiovascular disease mortality when measured before middle age? Pooled analyses of two prospective cohort studies from Scotland
To examine the association of physiological, behavioural and social characteristics in pre-middle age with future total and cardiovascular disease (CVD) mortality.
Methods and results
Risk factor data on 1503 individuals aged 16-35 years at baseline were collected in two prospective cohort studies using standard protocols. Their association with total and CVD mortality ascertained during 40 years of follow-up was summarized using Cox proportional hazards regression. A median follow-up of 39.6 years gave rise to 255 deaths (103 from CVD). In age-adjusted and sex-adjusted analyses, impaired lung function [one standard deviation increases in forced expiratory volume in 1 s: hazards ratio 0.69; 95% confidence interval 0.55, 0.86; and in forced vital capacity: 0.76; 0.59, 0.98], current cigarette smoking (4.16; 2.22, 7.80) and higher alcohol consumption (one standard deviation increase in standard units consumed: 1.20; 1.02, 1.41) were associated with CVD. In fully adjusted analyses associations generally held. For total mortality, these factors and obesity and socioeconomic disadvantage were predictive.
Conclusion
A range of risk factors measured before middle age were related to risk of total and CVD mortality up to four decades later, indicating that public health interventions should be implemented earlier in the life course than is currently the case.
Office for National Statistics. Mortality statistics: cause, 1995. London: The Stationery Office; 1997. (Series DH2, No 22).
2.
The World Health Report. Making a difference. Geneva: World Health Organization; 1999.
3.
PaffenbargerRSJrBrandRJSholtzRIJungDL.Energy expenditure, cigarette smoking, and blood pressure level as related to death from specific diseases. Am J Epidemiol1978; 108:12–18.
4.
HartCLDavey SmithGHoleDJHawthorneVM.Alcohol consumption and mortality from all causes, coronary heart disease, and stroke: results from a prospective cohort study of Scottish men with 21 years of follow up. BMJ1999; 318:1725–1729.
5.
IslesCGHoleDJGillisCRHawthorneVMLeverAF.Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey. BMJ1989; 298:920–924.
6.
KatzmarzykPTJanssenIArdernCI.Physical inactivity, excess adiposity and premature mortality. Obesity Rev2003; 4:257–290.
7.
LeeIMMansonJEHennekensCHPaffenbargerRSJr.Body weight and mortality. A 27-year follow-up of middle-aged men. JAMA1993; 270:2823–2828.
8.
BattyGDShipleyMJJarrettRJBreezeEMarmotMGDavey SmithG.Obesity and overweight in relation to disease-specific mortality in men with and without existing coronary heart disease in London: the Original Whitehall Study. Heart2006; 92:886–892.
9.
BattyGDGunnellDLangenbergCDavey SmithGMarmotMGShipleyMJ.Adult height and lung function as markers of life course exposures: associations with risk factors and cause-specific mortality. Eur J Epidemiol2006; 21:795–801.
10.
GunnellDWhitleyEUptonMNMcConnachieADavey SmithGWattGC.Associations of height, leg length, and lung function with cardiovascular risk factors in the Midspan Family Study. J Epidemiol Community Health2003; 57:141–146.
11.
LangenbergCShipleyMJBattyGDMarmotMG.Adult socioeconomic position and the association between height and coronary heart disease mortality: findings from 33 years of follow-up in the Whitehall Study. Am J Public Health2005; 95:628–632.
12.
BattyGDShipleyMJMarmotMDavey SmithG.Physical activity and cause-specific mortality in men: further evidence from the Whitehall Study. Eur J Epidemiol2001; 17:863–869.
13.
BattyGDLeeIM.Physical activity and coronary heart disease. BMJ2004; 328:1089–1090.
14.
SinDDWuLManSF.The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest2005; 127:1952–1959.
15.
Davey SmithGHartCHoleDMacKinnonPGillisCWattG, et al. Education and occupational social class: which is the more important indicator of mortality risk? J Epidemiol Community Health1998; 52:153–160.
16.
KuhDBen-ShlomoY, editors. A life course approach to chronic disease epidemiology (life course approach to adult health). 2nd ed.Oxford: Oxford University Press; 2004.
17.
McCarronPDavey SmithGOkashaMMcEwenJ.Smoking in adolescence and young adulthood and mortality in later life: prospective observational study. J Epidemiol Community Health2001; 55:334–335.
18.
Navas-NacherELColangeloLBeamCGreenlandP.Risk factors for coronary heart disease in men 18 to 39 years of age. Ann Intern Med2001; 134:433–439.
19.
PaffenbargerRSJrHydeRTWingALHsiehC.Cigarette smoking and cardiovascular diseases. IARC Sci Publ1986; 45–60.
20.
McCarronPDavey SmithGOkashaMMcEwenJ.Blood pressure in young adulthood and mortality from cardiovascular disease. Lancet2000; 355:1430–1431.
21.
StamlerJDyerARShekelleRBNeatonJStamlerR.Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. Cardiology1993; 82:191–222.
22.
KlagMJFordDEMeadLAHeJWheltonPKLiangKY, et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med1993; 328:313–318.
23.
BakerJLOlsenLWSorensenTI.Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med2007; 357:2329–2337.
24.
BjorgeTEngelandATverdalADavey SmithG.Body mass index in adolescence in relation to cause-specific mortality: a follow-up of 230,000 Norwegian adolescents. Am J Epidemiol2008; 168:30–37.
25.
GunnellDJFrankelSJNanchahalKPetersTJDavey SmithG.Childhood obesity and adult cardiovascular mortality: a 57-year follow-up study based on the Boyd Orr cohort. Am J Clin Nutr1998; 67:1111–1118.
26.
JeffreysMMcCarronPGunnellDMcEwenJDavey SmithG.Body mass index in early and mid-adulthood, and subsequent mortality: a historical cohort study. Int J Obes Relat Metab Disord2003; 27:1391–1397.
27.
McCarronPOkashaMMcEwenJDavey SmithG.Height in young adulthood and risk of death from cardiorespiratory disease: a prospective study of male former students of Glasgow University, Scotland. Am J Epidemiol2002; 155:683–687.
28.
Davey SmithGHartCBlaneDGillisCHawthorneV.Lifetime socioeconomic position and mortality: prospective observational study. BMJ1997; 314:547–552.
29.
IribarrenCJacobsDRKiefeCILewisCEMatthewsKARosemanJM, et al. Causes and demographic, medical, lifestyle and psychosocial predictors of premature mortality: the CARDIA Study. Soc Sci Med2005; 60:471–482.
30.
HemingwayHShipleyMChristieDMarmotM.Is cardiothoracic ratio in healthy middle aged men an independent predictor of coronary heart disease mortality? Whitehall Study 25 year follow up. BMJ1998; 316:1353–1354.
31.
HartCLMacKinnonPLWattGCUptonMNMcConnachieAHoleDJ, et al. The Midspan studies. Int J Epidemiol2005; 34:28–34.
32.
HawthorneVMGillisCRLorimerARCalvertFRWalkerTJ.Blood pressure in a Scottish Island community. BMJ1969; 4:651–654.
33.
HartCLDavey SmithG.Relation between number of siblings and adult mortality and stroke risk: 25 year follow up of men in the Collaborative study. J Epidemiol Community Health2003; 57:385–391.
34.
ReidDDBrettGZHamiltonPJJarrettRJKeenHRoseG.Cardiorespiratory disease and diabetes among middle-aged male civil servants. A study of screening and intervention. Lancet1974; 1:469–473.
35.
FerrieJEShipleyMJBreezeEDavey SmithG.Socioeconomic gradients in cardiorespiratory disease and diabetes in the 1960s: baseline findings from the GPO Study. Public Health2006; 120:685–695.
36.
General Register Office. Classification of Occupations 1966. London: Her Majesty's Stationery Office; 1960.
37.
General Register Office. Classification of Occupations 1966. London: Her Majesty's Stationery Office; 1966. pp. 1–148.
38.
World Health Organization. Physical status: the use and interpretation of anthropometry: report of a WHO expert committee, WHO Technical Report Series no 854. Geneva: World Health Organization; 1995.
39.
RoseGAHollandWWCrowleyEA.A sphygmomanometer for epidemiologists. Lancet1964; 1:296–300.
40.
HartCLDearyIJSmithGDUptonMNWhalleyLJStarrJM, et al. Childhood IQ of parents related to characteristics of their offspring: linking the Scottish Mental Survey 1932 to the Midspan Family Study. J Biosoc Sci2005; 37:623–639.
41.
AnnanWIsherwoodDM.An automated method for the direct determination of total serum cholesterol. J Med Lab Technol1969; 26:202–211.
42.
JubbJSLorimerARHawthorneVMMorganHGLawrieTD.Lipoprotein levels in apparently healthy men and women in the west of Scotland. Br Heart J1976; 38:1189–1193.
43.
Medical Research Council.Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their committee on the aetiology of chronic bronchitis. Lancet1965; 1:775–779.
44.
HartCDavey SmithG.Knowledge of cardiothoracic ratio adds to cardiovascular risk stratification. BMJ1998; 317:1321–1322.
45.
World Health Organization. Manual of the international statistical classification of diseases, injuries and causes of death. 9th rev. Geneva, Switzerland: World Health Organization; 1977.
46.
World Health Organization. ICD-10: International statistical classification of diseases and related health problems. 10th rev. Geneva, Switzerland: World Health Organization; 1992.
47.
IslesCGWalkerLMBeeversGDBrownICameronHLClarkeJ, et al. Mortality in patients of the Glasgow blood pressure clinic. J Hypertens1986; 4:141–156.
48.
CarlinJBGalatiJCRoystonP.A new framework for managing and analyzing multiply imputed data in Stata. Stata J2008; 8:49–67.
49.
CarpenterJRKenwardMGWhiteIR.Sensitivity analysis after multiple imputation under missing at random: a weighting approach. Stat Methods Med Res2007; 16:259–275.
50.
CoxDR.Regression models and life-tables. J R Stat Soc Ser B1972; 34:187–220.
51.
GalobardesBMcCarronPJeffreysMDavey SmithG.Association between early life history of respiratory disease and morbidity and mortality in adulthood. Thorax2008; 63:423–429.
52.
ChowdhuriSCrookEDTaylorHAJrBadrMS.Cardiovascular complications of respiratory diseases. Am J Med Sci2007; 334: 361–380.
53.
PearsonTAMensahGAAlexanderRWAndersonJLCannonROIIICriquiM, et al. Markers of inflammation and Cardiovascular Disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation2003; 107:499–511.
54.
O'CallaghanPAFitzgeraldAFogartyJGaffneyPHanbidgeMBoranG, et al. New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokers. Eur J Cardiovasc Prev Rehabil2005; 12:542–547.
55.
WennbergPAnderssonTBohmanM.Associations between different aspects of alcohol habits in adolescence, early adulthood, and early middle age: a prospective longitudinal study of a representative cohort of men and women. Psychol Addict Behav2000; 14:303–307.
56.
GorberSCSchofield-HurwitzSHardtJLevasseurGTremblayM.The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res2009; 11:12–24.
57.
KrokeAKlipstein-GrobuschKHoffmannKTerbeckIBoeingHHelanderA.Comparison of self-reported alcohol intake with the urinary excretion of 5-hydroxytryptophol: 5-hydroxyindole-3-acetic acid, a biomarker of recent alcohol intake. Br J Nutr2001; 85:621–627.
58.
PatrickDLCheadleAThompsonDCDiehrPKoepsellTKinneS.The validity of self-reported smoking: a review and meta-analysis. Am J Public Health1994; 84:1086–1093.
